NDC Package 66298-5140-1 Zyvox

Linezolid Injection, Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
66298-5140-1
Package Description:
300 mL in 1 BAG
Product Code:
Proprietary Name:
Zyvox
Non-Proprietary Name:
Linezolid
Substance Name:
Linezolid
Usage Information:
Linezolid is an antibiotic used to treat certain serious bacterial infections. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Linezolid also belongs to a class of drugs known as MAO inhibitors. It can increase the levels of certain natural substances in the body (such as dopamine, norepinephrine, serotonin) which can increase the chance of certain side effects and food and drug interactions. See How to Use, Side Effects, and Drug Interactions sections for more details.
11-Digit NDC Billing Format:
66298514001
NDC to RxNorm Crosswalk:
  • RxCUI: 1662285 - linezolid 600 MG in 300 ML Injection
  • RxCUI: 1662285 - 300 ML linezolid 2 MG/ML Injection
  • RxCUI: 1662285 - linezolid 600 MG per 300 ML Injection
  • RxCUI: 1662286 - ZYVOX 600 MG in 300 ML Injection
  • RxCUI: 1662286 - 300 ML linezolid 2 MG/ML Injection [Zyvox]
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Fresenius Kabi Norge As
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    NDA021131
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    06-05-2018
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 66298-5140-1?

    The NDC Packaged Code 66298-5140-1 is assigned to a package of 300 ml in 1 bag of Zyvox, a human prescription drug labeled by Fresenius Kabi Norge As. The product's dosage form is injection, solution and is administered via intravenous form.

    Is NDC 66298-5140 included in the NDC Directory?

    Yes, Zyvox with product code 66298-5140 is active and included in the NDC Directory. The product was first marketed by Fresenius Kabi Norge As on June 05, 2018 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 66298-5140-1?

    The 11-digit format is 66298514001. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-166298-5140-15-4-266298-5140-01